Standards; Pharmaceutical/API Drug Impurities/Metabolites;
MRE-3008F20 is a known human adenosine A3 receptor antagonist. MRE-3008F20 has also been studied extensively in recent advances in adenosine receptor ligand in pulmonary diseases.
Kalla, R., et al.: Med. Chem., 44, 265 (2009); Kishore, D.P., et al.: Bioorg. Medn. Chem., 21, 818 (2011);